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In most low-resource countries, surveillance of healthcare-associ-
ated infection (HAI) is limited or non-existent. A meta-analysis of 
HAI in low- and middle-income countries (LMIC) reported infec-
tion rates double those of developed countries, and a tripling of 
HAI rates in intensive care units (ICUs).[1] Central-line-associated 
bloodstream infections (CLABSI) are a type of device-associated 
HAI mainly encountered in the ICU setting. Data on CLABSI rates 
in LMIC are scant, particularly from neonatal intensive care unit 
(NICU) settings.
The use of central lines in NICUs is often unavoidable, with 
lines used for administration of intravenous fluids, blood products, 
inotropes, antibiotics and total parenteral nutrition (TPN). Even 
without the use of invasive devices, hospitalised neonates are at 
increased risk of infection owing to prematurity, poor skin inte-
grity and prolonged hospitalisation. Resource-limited countries 
contributing data to the International Nosocomial Infection Control 
Consortium (INICC) report NICU CLABSI rates of 3 - 4-fold higher 
than those documented by the US National Health Surveillance 
System (NHSN).[2,3]
In high-income-country NICUs, CLABSI rates declined dramati-
cally following widespread implementation of central-line bundles.[4] 
A CLABSI bundle is a strategy for insertion and maintenance of 
central lines, which includes several evidence-based best practices 
implemented simultaneously.[5,6] Central-line care bundle elements 
include: hand hygiene, optimal catheter-site selection, maximal 
barrier precautions at insertion, chlorhexidine skin antisepsis, daily 
review of line necessity, sterile line access, use of closed needleless 
intravascular catheter systems and ensuring the line dressing stays 
clean and intact.[5,6] 
Reductions in NICU CLABSI rates have been achieved in develop-
ing countries,[7] but data from African NICUs are extremely limited.[2] Our 
study reports the first CLABSI surveillance programme data from a 
public sector NICU in South Africa (SA) and aims to identify risk 
factors for CLABSI in this setting.
Methods
Study setting 
Tygerberg Hospital is a public sector teaching hospital in Cape Town, 
SA. The neonatal service provides care to both inborn babies and 
neonates referred from surrounding clinics and hospitals. In 2012 
and 2013, ~7 800 babies were born per year: 40% were low-birth-
weight (<2 500 g), 13% were very-low-birth-weight (<1 500 g) and 6% 
were extremely low-birth-weight (<1 000 g) infants.[8] The neonatal 
service includes the NICU, with 8 intensive-care beds and 4 high-care 
beds, as well as 112 ward beds. In 2013, there were 491 admissions to 
the NICU and 5 265 to the wards.[8]
Indications for central-line insertion in the NICU include require-
ment for TPN and/or inotropes, and neonates who require intrave-
nous fluids and/or antibiotics where peripheral intravenous access is 
not possible or difficult to obtain. Umbilical venous catheters (UVCs) 
and peripherally inserted central catheters (PICCs) are first- and 
second-choice central lines and are inserted by paediatric registrars 
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or medical officers. Central venous catheters (CVCs) and Broviac 
lines are inserted in patients in whom intravenous access is difficult, 
where attempts at insertion of other central lines have failed, and/or 
in post-surgical patients who need TPN. Broviac lines are inserted 
by the paediatric surgical team and CVCs by either the paediatric 
surgery or anaesthetic team. 
The Tygerberg Children’s Hospital (TCH) NICU CLABSI surveil-
lance and prevention programme was implemented on 9 August 2012, 
with the aim of determining baseline CLABSI rates through prospec-
tive surveillance and reducing CLABSI events through the use of 
central-line insertion and maintenance bundles. 
Study design 
The prospectively compiled NICU central-line register was used 
to identify cases and controls. All cases within the 2-year 
study period (9 August 2012 - 31 July 2014) were included, 
with 4 randomly selected controls per CLABSI event. Research 
randomiser (a computer program that generates random numbers) 
was used to select 4 controls for each CLABSI case, matching only 
for the year of the programme, i.e. 9 August 2012 - 31 July 2013 or 
1 August 2013 - 31 July 2014. 
Hospital and laboratory records for the cases and controls were 
retrospectively reviewed. If a ‘control’ folder was not available or 
the information in the folder was incomplete, the next randomly 
selected folder number was used. Information obtained from 
the folders for both cases and controls included: patient demo-
graphics, details of their NICU stay, and central-line informa-
tion. Additional information was obtained for all CLABSI cases: 
weight closest to CLABSI event onset, number of CLABSIs per 
patient, date of CLABSI event, pathogen isolated and antibiotic 
susceptibility, antibiotics used prior to and after CLABSI diagno-
sis, white cell count, platelet count, haemo globin and C-reactive 
protein result 48 - 72 hours prior to CLABSI and 24 - 48 hours 
after CLABSI.
All positive cultures from catheter tips submitted from the 
NICU during the study period and all blood culture results of 
babies who died or were transferred to other neonatal wards with 
central lines in situ were evaluated for possible missed CLABSI 
cases. Umbilical arterial lines were excluded from this study 
because surveillance of these lines was not part of the programme 
initially and none of the CLABSI cases was attributed to them. The 
CLABSI register was the primary data source used to determine 
total patients and central-line days to calculate the CLABSI rate.
Definitions
The US Centers for Disease Control and Prevention (CDC)/
National Healthcare Safety Network (NHSN) 2014 definitions for 
HAI were used.[9] CLABSI is defined as a laboratory-confirmed 
bloodstream infection (LC-BSI) in a patient with a central line in 
situ for at least 2 calendar days (where line insertion is day 1). It 
is still considered a CLABSI if an LC-BSI occurred within 1 day 
of line removal. The definitions for HAI and LC-BSI must be met 
before the definition of CLABSI can be applied, and other HAI 
must be excluded. The CLABSI rate per 1 000 central-line days is 
calculated by dividing the number of CLABSIs by the number of 
central-line days and multiplying the result by 1 000. Line days are 
the total number of days of exposure to central venous catheters by 
all patients in the selected population and time period. Definitions 
of multidrug resistance applied from Magiorakos et al.[10] were 
used to report on the antibiotic-susceptibility profile of pathogens. 
Mangram et al.’s[11] wound classification was used to classify the 
wounds of all the study participants who underwent surgery.
Statistical analysis
Normally distributed data were described using means and standard 
deviations; non-parametric data were described with medians and 
interquartile ranges. The χ2 test was used to compare demographics 
of CLABSI cases v. controls; p<0.05 was considered statistically sig-
nificant. Stepwise forward logistic regression analysis was performed 
to identify risk factors for CLABSI, reporting odds ratios (ORs) and 
95% confidence intervals (CIs). 
Ethical approval
Approval of the study (including a waiver of individual informed 
consent) was obtained from the Health Research Ethics Committee 
at Stellenbosch University (ref. no. S14/07/153).
Results
Fourteen CLABSI episodes were documented in the CLABSI register. 
One CLABSI episode was excluded from the study because it did 
not meet the CLABSI definition as per CDC/NHSN 2014 guidelines. 
An additional six ‘missed’ CLABSI episodes were added following 
review of records from babies who died with a central line in situ 
and those with a positive culture from their catheter tip, yielding a 
total of 19 CLABSI events, for which 76 controls were selected (a 
total of 95 study patients). The NICU CLABSI surveillance registers 
documented insertion of 706 central lines into 530 neonates during 
the first 2 years of the programme (a total of 3 187 central-line days). 
Nineteen CLABSI episodes in 17 patients were identified, yielding a 
CLABSI rate of 5.9/1 000 line days. The demographics of the study 
population are summarised in Table 1.
Nine of the CLABSI patients had medical indications for admis-
sion: hyaline membrane disease (n=3), meconium aspiration 
syndrome (n=2), presumed nosocomial sepsis (n=2), congenital 
cytomegalo virus infection (n=1) and pulmonary haemorrhage (n=1). 
Eight patients who had undergone abdominal surgery during their 
current or previous NICU admission developed CLABSI episodes 
(10/19; 53%), including one baby who had undergone surgery and 
who was admitted to the NICU for 107 days, experiencing three 
CLABSI events with different pathogens on three separate lines. Of 
the 8 babies who underwent surgery, 5 had a wound class III/IV 
(contaminated or dirty).[11] Comparison of septic markers 48 hours 
prior to and at/within 24 hours after the CLABSI event confirmed 
the possibility of sepsis, with a decrease in white cell count, platelets 
and/or raised C-reactive protein. Of the 5 neonates who died (26.3%), 
3 deaths were directly attributed to the CLABSI event, 1 to necrotising 
enterocolitis and 1 to congenital abnormalities. The babies who died 
from CLABSI were of very low birth weight (<1 500 g), premature, had 
medical indications for NICU admission and died within 48 hours of 
CLABSI diagnosis. The catheter dwell times in the ICU and time to 
CLABSI onset after insertion of different central-line types are sum-
marised in Table 2.
Of the 19 CLABSI events, 16 were monomicrobial and 3 were 
polymicrobial, with 2 pathogens each (a total of 22 laboratory-
confirmed pathogens). Gram-negative organisms predominated 
(12/22; 54%) followed by Gram-positives (5/22; 23%) and fungi 
(5/22; 23%). Antimicrobial susceptibility testing was performed on all 
isolates. Gram-negative organisms exhibited high rates of antimicrobial 
resistance: 6/7 Acinetobacter baumannii were multi drug-resistant 
and 4/5 Klebsiella pneumoniae produced extended-spectrum beta-
lactamases (Table 2). Fungi isolated were Candida albicans (n=3), 
C. parapsilosis (n=1) (all fluconazole susceptible), and C. krusei 
(n=1), susceptible to amphotericin B and voriconazole. For 14/19 
CLABSI events, patients were receiving antibiotics for other indications 
prior to the development of CLABSI. A change in the antimicrobial 
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treatment was made in 16/19 (84%) of patients, who showed clinical 
deterioration or had a change in their septic markers while awaiting 
blood culture results. After results of antimicrobial susceptibility 
testing were available, 9 patients required a change in treatment, 4 had 
therapy targeted to the pathogen isolated, 1 had an antimicrobial agent 
added, 1 remained on broad-spectrum antibiotics for suspected Gram-
negative sepsis, and there was 1 for whom the notes were incomplete. 
Three babies died before susceptibility testing results were available.
Two-thirds of the cohort were premature, with a lower median 
gestational age and birth weight among the cases than the controls 
(28 v. 34 weeks; p=0.003, and 1 170 v. 1 975 g; p=0.014). The median 
length of stay in the NICU was 7 days, but significantly longer in 
neonates who developed CLABSI (26 v. 5 days; p=<0.001). There 
were a greater proportion of male infants in both groups. HIV 
exposure rates were similar between cases and controls; of the 5 HIV-
exposed neonates who developed CLABSI, all tested HIV polymerase 
chain reaction (PCR)-negative within the first 2 weeks of life. Seven 
controls were HIV-exposed, but had an unknown HIV-PCR result. 
The predominant line types used were UVCs (58%) and PICCs 
(24%). Broviac lines (3%) and CVCs (15%) were less frequently 
used and almost exclusively inserted in the operating theatre (all 
three Broviac lines and 3/4 CVCs). Infection rates of lines inserted 
in the NICU were significantly lower than for those inserted in the 
operating theatre (12/78 (15%) v. 7/15 (41%); p=0.012). Only three 
Broviac lines were inserted over the 2-year study period and all three 
of the patients developed CLABSI.
Table 3 lists the factors associated with the development of CLABSI. 
In the stepwise forward logistic analysis, significant risk factors 
included insertion of a central line in the operating theatre (OR 8.1 
(95% CI 1.2 - 54.7); p=0.03) and length of NICU stay >30 days (OR 20.7 
(95% CI 2.1 - 203.2); p=0.009).
Discussion
The CLABSI rate of 5.9/1 000 lines in our NICU is similar to that 
reported from other LMIC but much higher than CLABSI rates in 
high-income settings. Limited resources, understaffing, overcrowding 
and the high rate of premature and low-birth-weight babies probably 
contributed to our high CLABSI rate. In our setting, CLABSI cases 
occurred more commonly in babies of lower gestational age, lower 
birth weight, those undergoing surgical procedures and those with a 
catheter dwell time >4 days.
Patients with central lines and NICU admission for >30 conse-
cutive days were 20 times more likely to develop a CLABSI event 
than those with shorter NICU stays. This result remained significant 
in multivariate analysis, although the CI was very wide. The wide 
CI can be attributed to the small number of cases. We postulate 
that the increased risk associated with CLABSI and long NICU stay 
may be due to increased risk of bacterial colonisation in critically ill 
patients with complicated and/or multisystem disease.[6,12]
In our setting, central lines inserted in the operating theatre 
(Broviac and CVCs) had an 8-fold increased risk of CLABSI com-
pared with lines inserted in the NICU. The increased risk could arise 
Table 1. Characteristics of the study population (N=95)
Variable assessed Patients, n (%)* (N=95) Cases (n=19) Controls (n=76) p-value
Gestational age (weeks), median (IQR) 33 (28 - 38) 28 (27 - 36) 34 (30 - 39) 0.003
Gestational age premature (<37 weeks) 66 (69) 15 (79) 51 (67) 0.316
Birth weight (g), median (IQR) 1 670 (1 130 - 2 765) 1 170 (960 - 2 120) 1 975 (1 170 - 2 838) 0.014
Length of stay in NICU (days), median (IQR) 7 (4 - 15) 26 (12 - 83) 5 (4 - 10) <0.001
Catheter dwell time in NICU (days)†
<4 
4 - 8
>8 
36 (38)
39 (41)
20 (21)
2 (11)
9 (47)
8 (42)
34 (45)
30 (39)
12 (16)
0.007
Gender (male) 61 (64) 13 (68) 48 (63) 0.669
HIV-exposed 21 (22) 5 (26) 16 (21) 0.621
Type of central line†
UVC
PICC
CVC
Broviac
55 (58)
23 (24)
14 (15)
3 (3)
6 (32)
6 (32)
4 (21)
3 (15)
49 (65)
17 (22)
10 (13)
0 (0)
0.001
Insertion venue†
NICU 
Theatre
Neonatal ward
82 (86)
8 (8)
5 (5)
12 (63)
6 (32)
1 (5)
70 (92)
2 (3)
4 (5)
0.001
Respiratory support in NICU 86 (91) 18 (95) 68 (89) 0.480
Inotropes in NICU 43 (45) 11 (58) 32 (42) 0.216
TPN via central line 72 (76) 16 (84) 56 (74) 0.338
Surgery during NICU stay 28 (29) 10 (53) 18 (24) 0.013
Final outcome (survived) 75 (79) 14 (74) 61 (80) 0.529
IQR = interquartile range; NICU = neonatal intensive care unit; UVC = umbilical venous catheter; PICC = peripherally inserted central catheter; CVC = central venous catheter; 
TPN = total parenteral nutrition. 
*Unless specified.
†For cells with <5 observations the Fisher’s exact test was used; for cells with >5 observations the χ2 test was used.
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during the insertion and/or the maintenance of these lines. CLABSI 
events related to insertion factors usually develop within 48 - 72 hours 
of line insertion, suggesting that line maintenance issues were more 
likely responsible for Broviac and CVC CLABSIs (median time to 
infection onset 20 and 7 days, respectively). Insertion of Broviac 
lines and CVCs is also technically more difficult and often inserted 
in patients with difficult venous access, or where attempts at insert-
ing other central-line types have failed. The literature has shown that 
TPN increases the risk of CLABSI. Broviac lines and CVCs were more 
likely to be used in patients who required longer periods of TPN, 
possibly contributing to infection risk. Another notable difference is 
that central-line insertion checklists are routinely completed for lines 
inserted in the NICU, but not for lines inserted in theatre. In light of 
these findings, the insertion bundle checklist should be implemented 
in theatre and education of all staff (not only NICU staff) involved 
in maintenance of surgically inserted lines undertaken. Central lines 
increase the risk of bloodstream infections.[12,13] Known risk factors 
for CLABSI include administration of TPN,[12,13] frequent manipu-
lation of the line,[14] open vascular systems,[15] not using needleless 
connections[6] and the use of multiple access ports.[6] Conflicting data 
exist on which type of central line is associated with the highest risk 
for CLABSI and when prolonged catheter dwell time becomes a risk 
factor.[13,16,17]
In our study, nearly 80% of neonates who experienced CLABSI 
events were premature and half of them required surgery. Although 
surgery during the NICU stay and catheter dwell time in the NICU 
were not significant in the multivariate analysis, an association 
was found in the univariate analysis. The limited data available for 
neonates undergoing surgery suggest that premature infants, those 
with stomas and those with multiple surgical interventions are at 
highest risk of developing a CLABSI.[18]
Our study did not confirm TPN administration as a significant 
risk factor for CLABSI, but we were unable to compare the duration 
of TPN administration in cases v. controls. Surgery during NICU 
stay, catheter dwell time and prolonged stay in the NICU could all 
be risk factors related to a specific group of patients requiring long-
term TPN. Future research is required to evaluate these factors and 
the cost-effectiveness of establishing a TPN unit for babies who are 
infection free but require long-term central lines for TPN.
Predominantly antibiotic-resistant Gram-negative pathogens were 
isolated. The high rate of antimicrobial resistance highlights the 
importance of our CLABSI surveillance and prevention programme 
and the need for continued antibiotic stewardship.
Study limitations included the small number of cases, making 
it difficult to extrapolate findings to the larger population; an 
unknown baseline CLABSI rate prior to implementing the CLABSI 
programme; and the retrospective collection of clinical data for 
the controls. This study did not specifically evaluate adherence to 
specific maintenance bundle elements (including number of access 
ports, use of needleless connectors and accessing central lines in 
a sterile manner). Other important CLABSI prevention strategies 
not explored in this study include daily assessment of the need for a 
central line, prevention of prematurity and promotion of early enteral 
feeding. Although the NICU had established a CLABSI registry, we 
identified six missed CLABSI events, suggesting a need for improved 
surveillance methods. 
Conclusion
Despite these limitations, to our knowledge, this study is the first 
to establish CLABSI rates and risk factors in an SA public sector 
NICU. The establishment of a baseline CLABSI rate has assisted 
us with setting targets for the programme, assessing the impact of 
interventions, and benchmarking ourselves against other similar 
NICUs. LMIC are faced with unique challenges, such as staff 
shortages, high patient turnover, and limited resources, making 
prevention of HAIs, such as CLABSI, very difficult. Support from 
hospital management and ongoing in-service training of all staff 
involved in the insertion and maintenance of central lines in 
neonates are vital to sustain and improve our CLABSI prevention and 
surveillance programme. Other resource-limited NICUs can benefit 
from our experience in implementing a CLABSI surveillance and 
prevention programme.
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